Y
Yifan Pharmaceutical Co Ltd
SZSE:002019
Yifan Pharmaceutical Co Ltd
SZSE:002019
Price:
13.36 CNY
0.68%
Market Closed
Updated:
Jun 3, 2024
Yifan Pharmaceutical Co Ltd
Accounts Receivables
|
Yifan Pharmaceutical Co Ltd
Accounts Receivables Peer Comparison
Comparables:
C
1093
H
3692
600436
600276
000538
Competitive Accounts Receivables Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Accounts Receivables | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
Y
|
Yifan Pharmaceutical Co Ltd
SZSE:002019
|
Accounts Receivables
¥1.1B
|
CAGR 3-Years
2%
|
CAGR 5-Years
2%
|
CAGR 10-Years
20%
|
|
C
|
CSPC Pharmaceutical Group Ltd
HKEX:1093
|
Accounts Receivables
¥6B
|
CAGR 3-Years
33%
|
CAGR 5-Years
23%
|
CAGR 10-Years
15%
|
|
H
|
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
|
Accounts Receivables
¥3.2B
|
CAGR 3-Years
5%
|
CAGR 5-Years
15%
|
CAGR 10-Years
N/A
|
|
|
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
|
Accounts Receivables
¥911.7m
|
CAGR 3-Years
15%
|
CAGR 5-Years
11%
|
CAGR 10-Years
16%
|
|
|
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
|
Accounts Receivables
¥5.2B
|
CAGR 3-Years
-3%
|
CAGR 5-Years
6%
|
CAGR 10-Years
12%
|
|
|
Yunnan Baiyao Group Co Ltd
SZSE:000538
|
Accounts Receivables
¥10B
|
CAGR 3-Years
19%
|
CAGR 5-Years
31%
|
CAGR 10-Years
31%
|
See Also
What is Yifan Pharmaceutical Co Ltd's Accounts Receivables?
Accounts Receivables
1.1B
CNY
1.1B
CNY
Based on the financial report for Mar 31, 2024, Yifan Pharmaceutical Co Ltd's Accounts Receivables amounts to 1.1B CNY.
What is Yifan Pharmaceutical Co Ltd's Accounts Receivables growth rate?
Accounts Receivables CAGR 10Y
20%
20%
Over the last year, the Accounts Receivables growth was 3%. The average annual Accounts Receivables growth rates for Yifan Pharmaceutical Co Ltd have been 2% over the past three years , 2% over the past five years , and 20% over the past ten years .
You don't have any saved screeners yet
